Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C51H72N5O10P |
Molecular Weight | 946.1186 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12N3CC[C@@]14C5=C(C=C(OC)C(=C5)[C@]6(C[C@@]7([H])CN(C[C@](O)(CC)C7)CCC8=C6NC9=C8C=CC=C9)C(=O)OC)N(C)[C@@]4([H])[C@](O)([C@H](O)[C@]2(CC)C=CC3)C(=O)N[C@H](C(C)C)P(=O)(OCC)OCC
InChI
InChIKey=BOELCLFVOBIXIF-MAKKXPIGSA-N
InChI=1S/C51H72N5O10P/c1-10-47(60)27-32-28-50(46(59)64-9,40-34(19-23-55(29-32)30-47)33-17-14-15-18-37(33)52-40)36-25-35-38(26-39(36)63-8)54(7)43-49(35)21-24-56-22-16-20-48(11-2,42(49)56)44(57)51(43,61)45(58)53-41(31(5)6)67(62,65-12-3)66-13-4/h14-18,20,25-26,31-32,41-44,52,57,60-61H,10-13,19,21-24,27-30H2,1-9H3,(H,53,58)/t32-,41-,42-,43+,44+,47-,48+,49+,50-,51-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/7882462
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7882462
Vinfosiltine (also known as S 12363) was developed as a vinca alkaloid derivative. It is known that vinca alkaloids are widely used in the medical treatment of breast cancer. Vinfosiltine participated in the phase II clinical trial to treat the patients with advanced breast cancer. The results have shown that the drug didn’t have significant single-agent activity. As a result, the development of vinfosiltine was discontinued.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7882462
a randomization was performed between two schedules with the same dose intensity, that is, 0.3 mg/m2 given weekly or 0.6 mg/m2 given every 2 weeks
Route of Administration:
Intravenous
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C932
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
||
|
NCI_THESAURUS |
C67422
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2103757
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY | |||
|
DTXSID10153930
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY | |||
|
70691387
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY | |||
|
100000079092
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY | |||
|
AW1UYE6Q9I
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY | |||
|
SUB00065MIG
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY | |||
|
C2378
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY | |||
|
6735
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY | |||
|
123286-00-0
Created by
admin on Fri Dec 15 17:47:11 GMT 2023 , Edited by admin on Fri Dec 15 17:47:11 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)